ADVISORY/Editor Roundtable: Progress and New Emerging Strategies for Cancer Gene Therapy Research.

Business Editors/Health/Medical Writers

ADVISORY...For Tuesday (April 27)

NEW YORK--(BUSINESS WIRE)--March 25, 2004

Alliance for Cancer Gene Therapy, Inc.

WHERE: Tuesday, April 27, 2004, 9:00 a.m. Penn Club, 30 West 44th
       Street.

WHEN: Please mark your calendar for Tuesday, April 27, 2004 at
      9:00 a.m. when Alliance for Cancer Gene Therapy, Inc. (ACGT),
      the only national foundation focused exclusively on funding
      cancer gene therapy research, will host an informative editor
      roundtable about the significant progress being made in this
      exciting area. The roundtable will take place at the Penn Club,
      30 West 44th St. 10th floor Spruce Room, in midtown Manhattan.

This informal, one-hour roundtable will include discussions by:

Dr. Savio Woo, Chairman of ACGT's Scientific Advisory Council, Chairman of the Carl C. Icahn Institute for Gene Therapy and Molecular Medicine at the Mount Sinai School of Medicine and former President of the American Society of Gene Therapy. Dr. Woo, one of the foremost experts in the field, will highlight some of the latest breakthroughs in cancer gene therapy, new research being supported by ACGT and the progress of the foundation's grant recipients.

Jeffrey Bartlett, Ph.D., Assistant Professor of Pediatrics and of Molecular Virology, Immunology, and Medical Genetics at Children's Research Institute, Columbus, Ohio. As a recent recipient of the prestigious Young Investigators national research grant from ACGT, Dr. Bartlett will discuss his original and innovative research in cancer gene therapy. He will also give an overview of ACGT's Young Investigators Grants as an essential step in funding research in the field of cancer gene therapy.

Edward Netter, President, will discuss the formation of ACGT, its mission and objectives and members and contributions of the distinguished Scientific Advisory Council.

Following these brief remarks, the roundtable will become an open forum for dialogue and Q&A between media attendees and researchers. Continental breakfast will be served. Toll-free call-in number (866-352-3799) for out-of-town media is available.

Alliance for Cancer Gene Therapy, Inc.

The mission of Alliance for Cancer Gene Therapy, Inc., Stamford, CT, is to increase private funding to support basic research, technology innovation, preclinical validation and clinical translation to expedite development of effective and safe therapies for cancer. In 2002, ACGT awarded $1.5 million in grants and in 2003 grants were approved for $2.5 million. The primary recipients of ACGT Awards and Grants are Young Investigators and Investigators - scientific researchers at academic institutions throughout the United States who have obtained Associate and Full Professor status.

ACGT is a 501 (c) (3) non-profit organization founded in 2001 by Edward Netter, a Greenwich, CT philanthropist and chairman of Geneve Corporation, and his wife Barbara, in collaboration with Dr. Savio Woo. ACGT is governed by a Board of Directors and advised by a Scientific Advisory Council of pre-eminent physicians.